AIM AIM ImmunoTech Inc
Company Analysis
Latest News
🔴 AIM ImmunoTech is trading 5% down today after shareholder approval of reverse split and dilutive share issuances
AIM ImmunoTech is trading 5% down at $0.26 following shareholder approval of a potential reverse stock split and significant new share issuances tied to...
AIM ImmunoTech Shareholders Approve Reverse Stock Split and Share Issuances
AIM ImmunoTech announced that stockholders approved all proposals at its Special Meeting on July 15, 2026. Key approvals include granting the Board of...
AIM ImmunoTech approves reverse split and share issuance, targeting NYSE compliance
AIM ImmunoTech (NYSE: AIM) shareholders approved all board proposals at a Special Meeting on July 15, 2026. The board is now authorized to enact a reverse...
🟢 AIM ImmunoTech is trading 5.47% up today despite no clear catalyst
AIM ImmunoTech is trading at $0.27 (+5.47%) today, with the upward move appearing to be an idiosyncratic gain as no new company-specific catalysts have been...
🔴 AIM ImmunoTech is trading 10.1% down
AIM ImmunoTech is trading at $0.25, down 10.1% from a comparison close of $0.28 during regular trading. This is a price-action follow-up, so a separate...
🔴 AIM ImmunoTech is trading 6.4% down today on dilution risks and upcoming special meeting
AIM ImmunoTech is trading at $0.27 (6.4% down) today, extending its weekly decline as the market weighs the impact of recent financing activities and dilution...
🔴 AIM extends move to 7.4% down
AIM is trading at $0.28, down 7.4% versus the comparison close of $0.31 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 AIM is trading 5.8% down today on dilution from recent financing and rights offerings
AIM is trading at $0.29 (5.8% down) following a series of recent dilutive financings that have increased share supply and pressured the stock. • The company...
🟢 AIM ImmunoTech Inc is trading 8.36% up in pre-market
AIM is trading at $0.30, up 8.36% in pre-market.
🔴 AIM is trading 6.8% down today amidst ongoing negative sentiment from recent dilutive financing
AIM is trading 6.8% down at $0.28, driven by continued investor reaction to recent dilutive financing activities. • This includes at-the-market offerings and...
🔴 AIM is trading 6.6% down today after financing dilution and prior listing-compliance pressure
AIM is trading at $0.29 (-6.57%) as financing dilution and listing compliance risks continue to weigh on the stock. • Recent pressure is tied to the company’s...
🔴 AIM makes sharp 10.9% drop
AIM is trading at $0.32, down 10.9% versus the comparison close of $0.36 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 AIM is trading 7% down today on dilutive financing and bankruptcy risk warnings
AIM is trading 7% down at $0.33 as investors react to disclosures regarding highly dilutive financings and explicit liquidity and bankruptcy risk warnings. •...
🔴 AIM Plunges 5.2% as Investors React to Looming Dilutive Financings and Bankruptcy Risk
• AIM ImmunoTech Inc. is seeking stockholder approval for highly dilutive financings and a potential reverse stock split due to disclosed liquidity strain. •...
🔴 AIM is trading 6.4% down today on mixed reaction to clinical and investor updates
AIM is trading at $0.34 (6.4% down) today following mixed market reactions to recent clinical and corporate developments. • The company announced the...
🔴 AIM is trading 5.6% down today amid a broader market risk-off tone
AIM is trading 5.6% down at $0.36 as the stock faces pressure from a broader market risk-off sentiment and general weakness in speculative assets. • The move...
AIM ImmunoTech files 13.1M share resale, enabling early investor exits
AIM ImmunoTech filed an SEC prospectus for the resale of up to 13,077,089 common stock shares. Selling stockholders will offer these shares, meaning the...
🔴 AIM ImmunoTech Inc is trading 87% down today after highly dilutive NYSE-compliance financing
AIM ImmunoTech Inc is trading 86.5% down today at $0.37 following a sharp decline triggered by a heavily dilutive equity and warrant financing package. • The...
🔴 AIM ImmunoTech Inc is trading 5.1% down today, extending selloff after dilutive financing for NYSE compliance
AIM ImmunoTech Inc is trading at $0.38 (5.1% down) in pre-market, extending a sharp selloff triggered by a major capital restructuring aimed at maintaining its...
🔴 AIM ImmunoTech Inc is trading 86.2% down today on heavily dilutive financing and NYSE compliance restructuring
AIM ImmunoTech Inc is trading 86.2% down at $0.38 as investors react to a heavily dilutive financing and compliance-driven restructuring of its capital...